HomeStocksMARKSANS

M

Marksans Pharma

MARKSANS Share Price

Healthcare
mtf MTF 2.66x

214.40

-1.35 (-0.63%)loss

as on 06 Aug 2025 at 15:57

1D
img
10
img
100% Buy
chartsarrowTradingViewarrow
TradingView Logo

Get 10+ Layouts, 100+ Indicators, Custom Timeframes & All Drawing Tools for FREE.

MARKSANS Stock Performance

Markets Today

High

0.00

Low

0.00

Open at

212.64

Prev Close

215.75

Volumes

5,359

Avg Price

0.00

Lower Circuit

172.60

Upper Circuit

258.90

Last Traded Details

Quantity

1

Time

15:57:45

Price Movement

0.00
214.40
0.00
Loss 0.00%down side
up side0.00% profit

Historical Performance

3 M High

270.70

3 M Low

207.00

1 Yr High

358.70

1 Yr Low

171.00

3 Yr High

358.70

3 Yr Low

45.40

5 Yr High

358.70

5 Yr Low

38.60

1-Year Performance

171.00
214.40
358.70
loss%down side
up side-∞% profit

MARKSANS Analyst Rating

Buy

Analysts have suggested that investors can Buy this Stock

- By Refinitiv from 2 analysts

Buy

100%

Hold

0%

Sell

0%


MARKSANS News

View All News arrow
news

No news for this stock at the moment.


MARKSANS Share Price History

View Price History arrow

Close Price

Volume

MARKSANS share price in last 10 trading sessions

DayOpenCloseChange%Day HighDay LowVolume
06 Aug 2025224.99215.75
-4.11% Loss
225.09213.5111,77,857
05 Aug 2025226.31225.73
-0.26% Loss
227.90223.806,46,773
04 Aug 2025225.60226.31
0.31% profit
227.50221.606,88,287
01 Aug 2025227.28224.86
-1.06% Loss
227.28220.2312,64,532
31 Jul 2025230.00227.45
-1.11% Loss
235.40226.308,84,409
30 Jul 2025228.00236.25
3.62% profit
241.00227.7533,72,403
29 Jul 2025226.50227.50
0.44% profit
231.40224.6517,33,885
28 Jul 2025228.10226.20
-0.83% Loss
235.00224.8076,56,743
25 Jul 2025231.60227.75
-1.66% Loss
233.45226.1017,45,298
24 Jul 2025238.15231.60
-2.75% Loss
242.45230.3022,26,047

MARKSANS Fundamentals

View Fundamentals arrow

Company Valuation

Market Cap (₹ Cr.)

9,719

PE Ratio

25.70

PB Ratio

3.96

Dividend Yield

0.37%

ROE

15.37%

ROCE

18.67%

Book Value (₹)

54.44

Face Value (₹)

1.00


Share Holding Pattern

Held ByJun 2024Sep 2024Dec 2024Mar 2025Jun 2025
Promoters
43.87%43.87%43.87%43.87%43.87%
Domestic Institutional Investors (DII)
3.75%4.10%4.30%4.56%5.50%
Foreign Institutional Investors (FII)
18.60%21.31%21.96%22.20%19.88%
Public Investors
29.47%26.77%26.24%25.77%26.75%
Government
0.00%0.00%0.00%0.00%0.00%

Promoters

Domestic Institutional Investors (DII)

Foreign Institutional Investors (FII)

Public Investors

Government


MARKSANS Investment Returns

1 Week

1 Month

3 Months

6 Months

9 Months

SIP Logo

Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.


MARKSANS Technicals

View Technicals arrow

Moving Averages

PeriodSimpleSignal
5-SMA224.02Bearish
10-SMA226.94Bearish
20-SMA240.15Bearish
50-SMA248.61Bearish
100-SMA235.08Bearish
200-SMA255.88Bearish

Technical Indicators

IndicatorValueAction
RSI(14)29.91Neutral
ATR(14)8.76Volatile
STOCH(9,6)19.14Oversold
STOCH RSI(14)15.30Oversold
MACD(12,26)-2.20Bearish
ADX(14)24.26Weak Trend

Summary of Technical Indicators for MARKSANS


Margin on MARKSANS

Order TypeMargin to PayLeverageQuantityTrade ValueMargin AmountActions
Intraday20.00%5.00 X
214.4042.88
MTF37.60%2.66 X
214.4080.61
Delivery100.00%1.00 X
214.40214.40

*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions.Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).


MARKSANS Financials Summary
View By:
Revenue
EBITDA
Net Profit
EPS
Revenue

In Crores

Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
577606653710725

MARKSANS Financials

View By:

Income Statement

In Crores

Quarterly StatementMar 2024Jun 2024Sep 2024Dec 2024Mar 2025
Revenue577606653710725
Expenses450462506543583
Operating Profit110128136139126
Operating Profit Margin %20%22%21%20%18%
Other Income1715112817
EBITDA126143147167142
Interest53333
Depreciation2120202123
Profit Before Tax100120125143116
Tax %23%26%22%27%22%
Net Profit78899810591
EPS22222

Balance Sheet

In Crores

Yearly Balance SheetMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Share Capital4141454545
Reserve & Surplus8461,0681,7002,0202,422
Minority Interest1921202123
Non Current Liabilities256184205273
Current Liabilities299356341390477
Total Liabilities1,2291,6402,1902,6813,240
Fixed Assets309428486776982
Capital Work in Progress12310927
Investments001271
Other Assets9081,2091,6941,8692,230
Total Assets1,2291,6402,1902,6813,240

Cash Flow

In Crores

Yearly Cash FlowMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Activities17999237230207
Investing Activities-45-84-259-141-49
Financing Activities-1580198-69-65
Net Cash Flow119941762193

Corporate Actions

DateCorporate ActionInformation
12th Aug 2025, Tuesday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q1 FY 25-26 Results
info
1st Aug 2025, Friday
DIVIDENDDividend
Final Dividend of ₹0.8 Per Share
19th May 2025, Monday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q4 FY 25-26 Results
info
11th Feb 2025, Tuesday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q3 FY 24-25 Results
info
12th Nov 2024, Tuesday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q2 FY 24-25 Results
info

The above dates are ex-dates.

View All Stock Events arrow

MARKSANS Revenue Growth

All values are in Crores

Revenue

Profit

Loss

Financial YearRevenueRevenue GrowthNet ProfitProfit Growth
FY 2024-251,244
37.63% profit
188
40.76% profit
FY 2023-24915
30.23% profit
134
30.03% profit
FY 2022-23716
-0.47% Loss
103
-1.08% Loss

Top Mutual Funds Invested in MARKSANS

logo

Bandhan Small Cap Fund Direct - Growth

1Y Returns

9.31 %

3Y Returns

32.49 %

5Y Returns

35.58 %

logo

UTI Large & Mid Cap Fund Direct - Growth

1Y Returns

3.63 %

3Y Returns

22.59 %

5Y Returns

26.51 %

logo

UTI Aggressive Hybrid Fund Direct - Growth

1Y Returns

4.57 %

3Y Returns

17.43 %

5Y Returns

20.88 %

logo

UTI Healthcare Fund Direct - Growth

1Y Returns

13.43 %

3Y Returns

26.36 %

5Y Returns

20.30 %

logo

Old Bridge Focused Fund Direct - Growth

1Y Returns

0.09 %

3Y Returns

0.00 %

5Y Returns

0.00 %

logo

Kotak Special Opportunities Fund Direct - Growth

1Y Returns

-2.28 %

3Y Returns

0.00 %

5Y Returns

0.00 %

logo

Kotak MNC Fund Direct - Growth

1Y Returns

0.00 %

3Y Returns

0.00 %

5Y Returns

0.00 %

logo

UTI Small Cap Fund Direct - Growth

1Y Returns

6.70 %

3Y Returns

21.40 %

5Y Returns

0.00 %

logo

Kotak Healthcare Fund Direct - Growth

1Y Returns

10.31 %

3Y Returns

0.00 %

5Y Returns

0.00 %

logo

TRUSTMF Small Cap Fund Direct - Growth

1Y Returns

0.00 %

3Y Returns

0.00 %

5Y Returns

0.00 %





Open IPOs

View All arrow
No Data

There are no Open IPOs at the moment.



What’s New In The Market
icon
C

Market Commentary

sentiment_img

The Nifty 50 opened at 24464.2, down 110.0 points or 0.45%. The Nifty Bank opened at 55215.65, declining 195.5 points or 0.35%. Both major indices showed negative movement at the opening.

13 minutes ago

icon
C

Gold and Silver Prices Rise Following US Tariff Hike on India

sentiment_img

Gold prices increased to Rs 101,360 per 10 gm after US President Donald Trump imposed fresh tariffs of up to 50% on India. Gold has shown steady growth over the past six months, with traders increasing activity in the safe haven asset following tariff announcements. The commodity reached its highest price of Rs 100,82 on June 22 and lowest at Rs 87,100 on April 7. Gold prices varied across cities, with Chennai recording the highest rate at Rs 101,470 per 10 gm, while Delhi traded at Rs 101,000 per 10 gm. Silver prices corrected by 2.95% to $37.01 levels due to industrial metals correction after a 50% tariff was imposed on copper. Silver was trading at Rs 1,14,050 per kilogram on the India Bullion Association, having recently reached a new high of Rs 1,16,641.

1 hour ago

icon
C

Market Commentary

sentiment_img

Gift Nifty opened at 24537 with a change of 0.5, representing 0.0% movement.

2 hours ago

FAQs

Marksans Pharma share price as of today is ₹ 214.40 as on 06 Aug 2025 at 15:57.
The 52W high of Marksans Pharma is ₹ 358.70 and 52W low is ₹ 171.00 as of 06 Aug 2025 at 15:57.
The past returns of Marksans Pharma share are -
  • Past 1 year: 7.98%
  • Past 3 years: 330.52%
  • Past 5 years: 364.57%
The PE and PB ratio of Marksans Pharma stands at 25.70 and 3.96 respectively as on 06 Aug 2025 at 15:57.
The EPS of Marksans Pharma is 2.00 for the quarter ended Mar 2025 and 8.40 for the financial year 2024-25.
The shareholding pattern of Marksans Pharma is as follows:
  • DIIs - 5.50%
  • FII - 19.88%
  • Promoters - 43.87%
  • Public Investors 26.75%
  • Goverenment - 0.00%
Yes, you can buy shares of Marksans Pharma online by opening Demat account with Dhan.
If you are a Dhan user already, you can buy Marksans Pharma stocks from Dhan Trading App or Web Trading Platform. If you are new to Dhan follow the below steps:
  1. Download the Dhan App to Open a Demat Account
  2. Navigate to the “Money Tab”
  3. Add money to your account
  4. Search for Marksans Pharma share
  5. Tap on “Buy”
With Dhan you can start a daily, weekly or monthly SIP in Marksans Pharma.
You can easily buy the shares of Marksans Pharma even after the markets are closed using the After Market Order feature on Dhan Trading App.
Candle bars with Screen
Invest in MARKSANS
Candle bars with Screen

Pay Zero Brokerage on Delivery

Candle bars with Screen

Open FREE Demat Account

Indian Flag

+91

Or Scan the QR Code to download the Dhan App

QR code Logo


Invest & Trade with a Trading
Platform That's icon

Open your Dhan Account in minutes!


border

Explore  |  Sitemap

*All securities mentioned on this website are exemplary and not recommendatory.

*Current prices on the website are delayed by 15 mins, login to check live prices.

We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.

Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.

That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.

©2021-2025 Raise Securities Private Limited (formerly Moneylicious Securities Private Limited). All rights reserved. CIN: U74999MH2012PTC433549 Raise Securities is part of Raise Financial Services.

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai – 400104
Corporate Office: 302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai - 400066, Maharashtra, India. Customer Care: 9987761000.


For any query / feedback / clarifications, email at help@dhan.co.

In case of grievances for any of the services rendered by Raise Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.


Disclaimer: All communications with the client via chat, phone, or email are for support purposes only. Any commitments or statements made by the agent (human or virtual) shall not be binding on the company.


DHAN is a brand owned by Raise Securities Private Limited. All DHAN clients are registered under Raise Securities Private Limited. Clients are advised to refer to our company as Raise Securities Private Limited when communicating with regulatory authorities.


Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances


Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit


Attention investors:

  1. Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
  2. Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
  3. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.


Raise Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account.


Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/


Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX


Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets


Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details |
MCXCCL Client Collateral details

Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Referral Terms & Conditions | Saarthi 2.0 Mobile App for Investors